Columbian | Vancouver
Eli Lilly backs Absci with $100 million investment
Southwest Washington
•
Jun 25, 2026
Eli Lilly
Latest Washington stories tagged “Eli Lilly”.
Columbian | Vancouver
KIT Radio Yakima
New Weight Loss Drug Shows Surprising Results In Clinical Trials
Columbia River Plateau
•
May 24, 2026
Columbian | Vancouver
FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity
Southwest Washington
•
Apr 1, 2026
My Northwest | Seattle
FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity
Puget Sound
•
Apr 1, 2026
Skagit Valley Herald | Mount Vernon
Trump unveils deal to expand coverage and lower costs on obesity drugs
North Cascades
•
Nov 7, 2025
UPI on Washington
Initial results show promise for Eli Lilly's new weight loss drug
Washington Non-Local Sources
•
Aug 11, 2025
Skagit Valley Herald | Mount Vernon
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
North Cascades
•
May 12, 2025
My Northwest | Seattle
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
Puget Sound
•
May 11, 2025
Skagit Valley Herald | Mount Vernon
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly
North Cascades
•
Mar 5, 2025
I Fiber One | Ephrata
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound
Columbia River Plateau
•
Dec 5, 2024
Columbian | Vancouver
Lilly weight-loss drug copycats dealt blow as shortage ends
Southwest Washington
•
Oct 3, 2024
Skagit Valley Herald | Mount Vernon
FDA approves a second Alzheimer's drug that can modestly slow disease
North Cascades
•
Jul 2, 2024
Skagit Valley Herald | Mount Vernon
Alzheimer's drug that can slow disease gets backing from FDA advisers
North Cascades
•
Jun 10, 2024
I Fiber One | Ephrata
Alzheimer's drug that can slow disease gets backing from FDA advisers
Columbia River Plateau
•
Jun 10, 2024
I Fiber One | Ephrata
Weight loss, diabetes drugs propel Eli Lilly to largely better-than-expected forecast for 2024
Columbia River Plateau
•
Feb 6, 2024
Yakima Herald
Column: What got lost in a year of hype about obesity drugs
Columbia River Plateau
•
Dec 31, 2023
Skagit Valley Herald | Mount Vernon
Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heights
North Cascades
•
Aug 8, 2023
I Fiber One | Ephrata
Soaring sales of diabetes drug Mounjaro, often used for weight loss, sends Eli Lilly to new heights
Columbia River Plateau
•
Aug 8, 2023
Skagit Valley Herald | Mount Vernon
Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety risk
North Cascades
•
Jul 17, 2023
Yakima Herald
Column: Eli Lilly's new weight-loss drug is even better than Ozempic
Columbia River Plateau
•
Jul 8, 2023
Yakima Herald
Commentary: By avoiding funding Alzheimer's research, the government is cutting seniors' life spans
Columbia River Plateau
•
May 27, 2023
I Fiber One | Ephrata
Eli Lilly says experimental drug slows Alzheimer's worsening
Columbia River Plateau
•
May 3, 2023